P&T committee meetings

Evidence and decisions published 14 of 52

Programs below post clinical reviews and meeting outcomes.

Alabama Medicaid Agency
Pharmacy and Therapeutics Committee Meetings (opens in a new tab)
Meeting announcements, agendas, minutes, and a clinical packet for each quarterly meeting, archived by year from 2020 to 2026.
Arizona Health Care Cost Containment System
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas, minutes, a clinical presentation and recommendation slides for every meeting from 2022 to 2026, with written public testimony posted verbatim. The link offered for the October 2025 minutes opens the January 2026 agenda.
Iowa Department of Health and Human Services, Iowa Medicaid
Pharmaceutical and Therapeutics Committee Info (opens in a new tab)
Per-drug monographs on the archived meeting pages from 2024 to 2026, with minutes from 2023 to 2026, agendas, the committee roster and the conflict of interest policy. The monograph pages sit apart from the minutes.
Kentucky: Cabinet for Health and Family Services, Department for Medicaid Services
Pharmacy and Therapeutics Advisory Committee (opens in a new tab)
A document for each meeting from 2023 to 2026 reviewing the drugs before the committee and setting out its options, the committee’s recommendations with its votes, and the Commissioner’s final decisions as a separate record. Earlier meetings are released only in answer to an open records request.
Missouri: Department of Social Services, MO HealthNet
Drug Prior Authorization Committee meetings (opens in a new tab)
Roughly forty per-drug and per-class proposals for each quarterly meeting from 2024 to 2026, each giving the epidemiology, the utilization and spending, and the grounds on which the issue was selected. Earlier meetings are held by the Missouri State Archives.
New Jersey: Department of Human Services, Division of Medical Assistance and Health Services
Drug Utilization Review Board (opens in a new tab)
The document packet the board votes on, a meeting summary, and a verbatim transcript of the discussion, for every quarterly meeting from 2006 to 2026.
New York: Department of Health
Medicaid Drug Utilization Review Program (opens in a new tab)
A therapeutic class review packet, a written meeting summary and a webcast transcript for each meeting from 2021 to 2026, with annual drug utilization review reports from 2020. Earlier meetings are in a separate historic archive.
North Dakota: Department of Health and Human Services, through Acentra Health
North Dakota Medicaid DUR Board (opens in a new tab)
An agenda, minutes and a handout for every quarterly meeting from 2020 to 2026, the handout carrying utilization data and clinical treatment overviews with numbered references.
Oklahoma Health Care Authority
DUR Board meeting agendas (opens in a new tab)
A board packet for every monthly meeting from 2004 to 2026, carrying market news, product summaries and College of Pharmacy recommendations per class. A meeting’s minutes arrive inside the following month’s packet.
Oregon Health Authority, through the Oregon State University Drug Use Research and Management program
Meetings and Agenda (opens in a new tab)
A complete evidence packet, written testimony, signed recommendations and minutes as four separate documents for every meeting from 2011 to 2026.
Department of Social Services, South Dakota Medicaid
Pharmacy and Therapeutics Committee, Boards and Commissions (opens in a new tab)
A board packet for every meeting from 2015 to 2026 carrying the written drug reviews, utilization by therapeutic class and prior authorization updates, with agendas and minutes.
Tennessee: Division of TennCare, through Optum Rx
TennCare Pharmacy Advisory Committee (opens in a new tab)
A review packet for each meeting carrying new drug reviews with named pivotal trials and standard and abbreviated class reviews, with minutes and agendas. Documents opened for 2025 and 2026; the index does not show how far back the record runs.
Texas: Health and Human Services Commission
Drug Utilization Review Board documents (opens in a new tab)
A therapeutic class review written by the program’s contractor and attached to each agenda item, with minutes recording roll-call votes on prior authorization criteria, from July 2025 onward. Earlier meetings are released only in answer to a records request.
Washington State Health Care Authority
Meetings and materials, Pharmacy and Therapeutics Committee and Drug Utilization Review Board (opens in a new tab)
Quarterly meeting dates, topic agendas, recordings and transcripts, committee motions, drug class reviews, and the stakeholder list that distributes agendas by email, for the current calendar year. A drug class review comes down 30 days after its meeting, by the program’s own statement.

Decisions published, evidence not published 30 of 52

Programs below post minutes or an equivalent record of what the committee changed, but do not publish clinical reviews.

Arkansas Department of Human Services, through Prime Therapeutics
Arkansas provider documents, DUR Board (opens in a new tab)
Drug Utilization Review Board agendas and minutes from 2019 to 2026, alongside memoranda of approved prior authorization criteria indexed back to 2010.
California: Department of Health Care Services, Medi-Cal Rx
Medi-Cal Rx Drug Utilization Review Board (opens in a new tab)
Agenda packets and minutes for every quarterly meeting from 2022 to 2026, covering utilization review, quality measures and drug utilization alerts.
Colorado: Department of Health Care Policy and Financing
Pharmacy and Therapeutics Committee (opens in a new tab)
Quarterly agendas, signed minutes, and a drug class review announcement giving the classes under review with rebate and testimony deadlines, for meetings from 2025 to 2026.
Connecticut: Department of Social Services
Pharmacy information, Connecticut Medical Assistance Program (opens in a new tab)
Minutes of the twice-yearly meetings from 2004 to 2024, the committee bylaws, and a Department of Social Services document accepting the recommendations class by class.
Department of Defense: Defense Health Agency, Military Health System
DOD Pharmacy & Therapeutics Committee (opens in a new tab)
Quarterly meeting dates, the drug classes under review at each meeting, designated newly approved drugs, utilization management items, meeting minutes, and the uniform formulary request for quote deadlines. Every meeting from 1998 to 2025 is indexed, one year at a time.
Georgia: Department of Community Health
Drug Utilization Review Board (opens in a new tab)
Per-meeting handouts carrying the prior meeting’s minutes, board recommendations by drug, and a separate document recording the decisions the department adopted, for every meeting from 2024 to 2026.
Hawaii: Med-QUEST Division
Med-QUEST Drug Use Review Program (opens in a new tab)
Public meeting notices, agendas and minutes for the Drug Utilization Review Board, covering program administration, prescription monitoring data and board bylaws. Meetings from 2021 and from 2023 to 2026; nothing is posted for 2022.
Illinois: Department of Healthcare and Family Services
Committee on Drugs and Therapeutics (opens in a new tab)
Minutes from 2020 to 2026 and agendas from 2021 to 2026 on a dedicated archive page, with a published class review schedule and a public testimony registration form.
Kansas: Department of Health and Environment
Drug Utilization Review Board (opens in a new tab)
Quarterly agendas and minutes from 2017 to 2026, the minutes structured as topic, discussion and decision with public comment recorded per item.
Louisiana Department of Health
Pharmaceutical and Therapeutics Committee (opens in a new tab)
Agendas from 2011 to 2026, the classes scheduled for review, annual preferred drug list reports and prior authorization implementation schedules. Minutes are posted for recent meetings only.
Department of Health and Human Services, MaineCare
MaineCare Drug Utilization Review Committee (opens in a new tab)
An unbroken minutes series from 2020 to 2025 with agendas from 2021 to 2026, the minutes carrying a drug-by-drug clinical narrative for each new drug.
Massachusetts: MassHealth
Drug Utilization Review Board meeting minutes (opens in a new tab)
Indexed agendas and minutes from December 2010 to September 2026, each posted as a PDF and as plain text. None of the minutes would open on the day this was checked.
Michigan: Department of Health and Human Services, through Prime Therapeutics
Michigan Pharmacy and Therapeutics Committee (opens in a new tab)
An agenda, minutes and a materials packet for every quarterly meeting from 2021 to 2026, the packet carrying new drug descriptions, prior authorization criteria and the full preferred drug list.
Minnesota: Department of Human Services
Drug Formulary Committee (opens in a new tab)
Minutes from 2020 to 2026 recording each drug, the vote margin and the exact criterion language the committee amended. The packet the committee reads is posted for the meeting ahead and comes down once that meeting has passed.
Mississippi: Division of Medicaid
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas and detailed minutes for every meeting from 2004 to 2026, reproducing the resulting preferred and non-preferred tables with changes highlighted.
Montana: Department of Public Health and Human Services
Drug Utilization Review Board (opens in a new tab)
Agendas and minutes for the six or seven meetings a year from 2023 to 2026, with earlier meetings on a separate archive page the board page links to.
Nebraska: Department of Health and Human Services, through the pharmacy benefit administrator
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas and minutes for about 36 meetings from 2009 to 2026, the minutes carrying a roll-call vote naming each member and reproducing the adopted drug criteria in full.
Nevada: Division of Health Care Financing and Policy
Silver State Scripts Board (opens in a new tab)
Agendas, near-verbatim minutes, public comments and manufacturer testimonials for every meeting from 2021 to 2026.
New Hampshire: Department of Health and Human Services, through Prime Therapeutics
New Hampshire Medicaid pharmacy (opens in a new tab)
Drug Utilization Review Board agendas from 2014 to 2026 and minutes from 2021 to 2025, with prior authorization criteria sheets and superseded preferred drug lists.
North Carolina: Department of Health and Human Services, NC Medicaid
Preferred drug list meeting archive (opens in a new tab)
Agenda and minutes for nineteen review panel meetings from 2018 to 2026, with recommendations, speakers and the recorded vote per category.
Ohio: Department of Medicaid
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas and minutes for every quarterly meeting from 2012 to 2026, the minutes naming each drug, the department recommendation, the vote and the resulting criteria in full.
Pennsylvania: Department of Human Services
Pharmacy and Therapeutics Committee (opens in a new tab)
Agendas on the department site and recommendation documents carrying significant points of discussion by drug class, distributed through a mailing list archive covering 2010 and 2012 to 2025. Documents arrive as attachments to an email.
Rhode Island: Executive Office of Health and Human Services
Pharmacy and Therapeutics Committee (opens in a new tab)
Twenty years of quarterly minutes, from 2006 to 2026, as a per-class table giving compliance, the recommendation, the discussion and the vote, with public testimony logged by speaker. Only the current agenda is kept.
South Carolina: Department of Health and Human Services, through the pharmacy benefit administrator
Pharmacy and Therapeutics Committee (opens in a new tab)
Seventy-five sets of minutes, from 2004 to 2026, recording each preferred drug list change, the mover and seconder, and the manufacturers who spoke. The meeting materials table reads that none are available, for every year.
Department of Health and Human Services, Utah Medicaid
Drug Utilization Review Board (opens in a new tab)
Minutes from 2022 to 2026, listed one year at a time, recording for each topic the information presented, the board’s discussion and the action taken, naming members and their reasoning, with a recording of each meeting.
Department of Vermont Health Access
Drug Utilization Review Board (opens in a new tab)
Agendas and minutes for the five to seven meetings a year from 2019 to 2026, the minutes recording each board decision with the adopted prior authorization criteria set out in full.
Virginia: Department of Medical Assistance Services
Virginia Medicaid Pharmacy Services, P&T Committee (opens in a new tab)
Minutes from 2005 to 2026 across a current list and an archive section, with committee bylaws and a document describing the recommendations process. Only the current agenda is kept.
West Virginia: Bureau for Medical Services
Pharmaceutical and Therapeutics Committee meetings (opens in a new tab)
Agendas, minutes and a changes-only document per meeting recording the resulting preferred drug list edits, with a speaker disclosure form. Meetings listed from 2022 to 2026, though only the 2025 and 2026 documents open.
Wisconsin: Department of Health Services, ForwardHealth
Prior Authorization Advisory Committee (opens in a new tab)
A recommendations summary for each of the two meetings a year from 2012 to 2026, giving every product’s market share, its current and recommended status, and any change the department or the secretary made to the committee’s recommendation.
Wyoming Department of Health, through the University of Wyoming
Wyoming Medicaid Drug Utilization Review (opens in a new tab)
Minutes for every quarterly meeting from 2010 to 2026, transcribing manufacturer presentations, the board’s clinical questions and the motion with its conditions, with published comment forms.

Schedule only 8 of 52

Programs below post meeting dates and agendas, but do not publish meeting outcomes.

Alaska Department of Health, Division of Health Care Services
Medicaid Pharmacy and Therapeutics Committee (opens in a new tab)
Committee information, a form for manufacturers to submit clinical evidence, and the schedule of drug classes to be reviewed in state fiscal years 2023 to 2027. Documents come down 25 months after they are posted, and the state library archive that receives them stops at 2022.
Department of Health and Social Services, Delaware Medicaid
Pharmacy Corner document repository (opens in a new tab)
Committee bylaws, member list, meeting logistics, public testimony guidelines and a single current agenda. A new version replaces the old one at the same address.
District of Columbia: Department of Health Care Finance, through Prime Therapeutics
DC Medicaid preferred drug list and P&T Committee (opens in a new tab)
Meeting notices and agendas for every quarter from 2007 to 2026, naming the classes under review, with speaker testimony guidelines. No minutes are published.
Florida: Agency for Health Care Administration
Pharmacy meeting notices (opens in a new tab)
The agenda for the next Pharmaceutical and Therapeutics and Drug Utilization Review meeting, with public comment forms and quarterly drug utilization reports from 2022 to 2026. Past agendas are not kept.
Idaho: Department of Health and Welfare
Pharmacy and Therapeutics Committee (opens in a new tab)
Committee bylaws, a drug class review schedule, a written submission policy for manufacturers, and an agenda for each meeting on the state public meeting portal. No minutes and no recordings are published.
Indiana: Family and Social Services Administration, Office of Medicaid Policy and Planning
OMPP meetings and agendas (opens in a new tab)
Monthly Drug Utilization Review Board agendas from 2020 to 2026, with agendas for the mental health quality committee and the vendor’s therapeutics committee. No minutes are published.
Maryland Department of Health
Pharmacy and Therapeutics Committee (opens in a new tab)
The next meeting date, a public testimony registration form and an attendance registration link. The index of minutes and every file it lists return a not-found error.
New Mexico: Health Care Authority
Medicaid pharmacy (opens in a new tab)
The current preferred drug list and a quarterly public meeting notice giving the date, time and location. No agendas, minutes or reviews are posted; the notice gives the agenda out by email from a named member of staff.